Objective: Glutamate receptors, which play a major role in the physiology and pathology of central nervous system gray matter, are also involved in the pathophysiology of white matter. However, the cellular and molecular mechanisms responsible for excitotoxic damage to white matter elements are not fully understood. We explored the roles of AMPA and GluR5 kainate receptors in axonal Ca 2ϩ deregulation. Methods: Dorsal column axons were loaded with a Ca 2ϩ indicator and imaged in vitro using confocal microscopy. Results: Both AMPA and a GluR5 kainate receptor agonist increased intraaxonal Ca 2ϩ in myelinated rat dorsal column fibers. These responses were inhibited by selective antagonists of these receptors. The GluR5-mediated Ca 2ϩ increase was mediated by both canonical (ie, ionotropic) and noncanonical (metabotropic) signaling, dependent on a pertussis toxin-sensitive G protein/ phospholipase C-dependent pathway, promoting Ca 2ϩ release from inositol triphosphate-dependent stores. In addition, the GluR5 response was reduced by intraaxonal NO scavengers. In contrast, GluR4 AMPA receptors operated via Ca 2ϩ -induced Ca 2ϩ release, dependent on ryanodine receptors, and unaffected by NO scavengers. Neither pathway depended on L-type Ca 2ϩ channels, in contrast with GluR6 kainate receptor action. 1 Immunohistochemistry confirmed the presence of GluR4 and GluR5 clustered at the surface of myelinated axons; GluR5 coimmunoprecipitated with nNOS and often colocalized with neuronal nitric oxide synthase clusters on the internodal axon. Interpretation: Central myelinated axons express functional AMPA and GluR5 kainate receptors, and can directly respond to glutamate receptor agonists. These glutamate receptor-dependent signaling pathways promote an increase in intraaxonal Ca 2ϩ levels potentially contributing to axonal degeneration.
The precise mechanisms of glutamate-mediated toxicity in white matter are not completely established. This transmitter likely causes damage to glia given that both astrocytes and oligodendrocytes express a variety of glutamate receptors, [2] [3] [4] [5] [6] [7] [8] with oligodendrocytes being particularly vulnerable to excitotoxic cell death. 9 -12 Whether glutamatergic signaling is directly involved in irreversible axonal injury in disorders such as stroke, multiple sclerosis, and neurotrauma is not known, though a role for glutamate-dependent excitotoxicity is suspected given the protective effects of ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate antagonists in models of spinal cord injury, stroke, and experimental autoimmune encephalomyelitis. 2, 4, [13] [14] [15] [16] [17] [18] The beneficial effect of glutamate antagonism was hypothesized to be caused by sparing of glia and myelin, but the observed axonal protection remains unexplained. To date, no conclusive data exist showing expression of functional glutamate receptors on central myelinated axons. Here, we show that myelinated dorsal column axons express glutamate receptor subunit 4 (GluR4) AMPA receptors and GluR5 kainate receptors; the GluR5 effect is mediated in large part via a noncanonical mechanism through activation of G protein, phospholipase C, and release of Ca 2ϩ from intracellular stores by activation of inositol triphosphate (IP3) receptors. GluR4 AMPA receptors, on the other hand, appear to participate in Ca 2ϩ -induced Ca 2ϩ release (CICR) through ryanodinedependent Ca 2ϩ stores.
Materials and Methods

Ca 2ϩ Imaging
Experiments were performed on spinal cord dorsal columns in vitro from adult Long-Evans male rats. Thoracic spinal cord was removed and placed in cold oxygenated zero-Ca 2ϩ solution containing (in mM) NaCl 126, KCl 3, MgSO 4 2, NaHCO 3 26, NaH 2 PO 4 1.25, MgCl 2 2, dextrose 10, and EGTA 0.5, oxygenated with 95% O 2 /5% CO 2 . Freshly excised dorsal columns were loaded for 2 hours with Ca 2ϩ -insensitive reference dye (250M red dextran-conjugated Alexa 594) to allow identification of axon profiles, and the dextran-conjugated Ca 2ϩ indicator Oregon Green BAPTA-1 (250M) (both from Molecular Probes, Eugene, OR) using a suction electrode applied to the cut end. The final dye concentration in the axons was estimated at approximately 2M. Tissue was transferred to a custom-built chamber on a Nikon (Toronto, Ontario) C1 confocal microscope and imaged every 60 seconds at 37°C with a 60ϫ 1.0 NA water immersion lens warmed to 37°C. Green signal was ratioed against the Ca 2ϩ -insensitive red channel; then percentage change during exposure to various agents compared with control was calculated. Pertussis toxin (PTX) was first activated by adding adenosine triphosphate (1mM) and glutathione (2mM), and incubated at 37°C overnight. Final PTX concentration in the loading pipette was 5M.
Immunohistochemistry
For light microscopy, deeply anesthetized rats were perfused with saline, then 4% paraformaldehyde in 0.1M phosphate buffer. Dorsal columns were excised, postfixed, and immersed in 20% sucrose overnight. Forty-micrometer sections were cut with a freezing microtome and washed with Tris buffer containing 1% Triton X-100 (Sigma Labs, St. Louis, MO). After 1 hour block with 10% normal goat serum in Triton X-100, primary antibodies against GluR5 (1:50; Chemicon International, Temecula, CA), GluR4 (1:50; Chemicon), neuronal nitric oxide synthase (nNOS; 1:100; Abcam, Cambridge, MA), and neurofilament 160 (NF160; 1:1,000; Sigma) were applied for 24 hours at 4°C. Secondary antibodies (Texas red anti-rabbit or anti-mouse; Cedarlane, Burlington, NC) were applied at a 1:100 dilution, and Alexa 488 anti-goat and anti-rabbit (Molecular Probes) at 1:500 for 1 hour at room temperature. Neurofilament 160 directly conjugated to Alexa 660 was used at 1:100 dilution. Slides were imaged on a Nikon C1 confocal microscope with a 60ϫ 1.4 NA oil immersion objective.
Immunohistochemistry, immunoelectron microscopy, and immunochemistry were performed using standard techniques as described previously.
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Statistics
Means are shown with standard deviations. Statistical differences were computed using analysis of variance with Tukey's test for multiple comparisons using Igor (Wavemetrics, Lake Oswego, OR) unless otherwise stated. N values are numbers of individual axons unless otherwise noted.
Results
We measured relative [Ca 2ϩ ] changes in live adult rat spinal cord dorsal column myelinated axons using Oregon Green-488 BAPTA-1 fluorescence (Fig 1) . GluR5-containing kainate receptors (hereafter referred to as GluR5s') were activated by the selective agonist (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA 10M), 20 whereas the relatively selective agonist AMPA (100M) was used to activate AMPA receptors. Both agents induced an increase in axoplasmic Ca 2ϩ -dependent fluorescence (F Ca.ax ) (mean increase after 30 minutes: 130 Ϯ 63%, n ϭ 53 axons for ATPA; 83 Ϯ 50%, n ϭ 56 for AMPA), which was largely blocked by the combined AMPA/ kainate receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX 50M, F Ca.ax increase at 30 minutes: 17 Ϯ 14%, n ϭ 32 with ATPA; 18 Ϯ 20%, n ϭ 45 with AMPA; p ϭ 10 Ϫ5 vs agonist alone, both groups). In contrast, the GluR5 21 selectively reduced the ATPA-induced response (F Ca.ax increase 38 Ϯ 35%, n ϭ 48, p ϭ 10 Ϫ5 vs ATPA alone) but had no effect on the AMPA-induced Ca 2ϩ increase (85 Ϯ 19%, n ϭ 27, p Ϸ 1 vs AMPA alone). Comparing the Ca 2ϩ responses elicited by AMPA versus ATPA in the presence of UPB302 also yielded a highly significant difference ( p ϭ 6 ϫ 10 Ϫ4 ), further supporting the relatively selective block of GluR5 over AMPA receptors by this antagonist. Conversely, the AMPA receptor antagonist 1-naphthyl acetyl spermine did not reduce the ATPA-induced F Ca.ax increase (133 Ϯ 73%; n ϭ 44; p ϭ 1) but strongly reduced the response elicited by AMPA (11 Ϯ 24%; n ϭ 32; p ϭ 10 Ϫ5 ) (see Fig 1) . Taken together, these findings strongly suggest that ATPA preferentially activated GluR5s,' whereas AMPA acted as a selective agonist of AMPA receptors in our tissue.
To further characterize the source of Ca 2ϩ mobilized by activation of GluR5 or AMPA receptors, we performed experiments in Ca 2ϩ -free perfusate, with the addition of 0.5mM EGTA (Fig 2) . Under these conditions, the ATPA-induced Ca 2ϩ increase was significantly reduced but not abolished (F Ca.ax increase: 43 Ϯ 31%, n ϭ 36, p ϭ 10 Ϫ5 vs ATPA in normal Ca 2ϩ ), suggesting that part of the GluR5-dependent effect was mediated by Ca 2ϩ release from intracellular stores independent of extracellular Ca 2ϩ . In contrast, the AMPA response was virtually abolished in zero-Ca 2ϩ perfusate (F Ca.ax increase: 6 Ϯ 23%, n ϭ 27, p ϭ 10 Ϫ5 vs AMPA in normal Ca 2ϩ ). We previously showed that activation of axonal voltage-gated Ca 2ϩ channels leads to Ca 2ϩ release from axonal Ca 2ϩ stores and is an important mechanism contributing to Ca 2ϩ overload in damaged central axons. 22 We therefore examined the effect of nimodipine (10M) to investigate any involvement of L-type Ca 2ϩ channels. This blocker did not reduce the ATPA-or the AMPAinduced F Ca.ax increase (see Fig 2) , indicating that these receptors induced axonal Ca 2ϩ increases independently of L-type Ca 2ϩ channel activation. Kainate receptor signaling may occur either ionotropically or metabotropically via receptor coupling to G proteins. 23, 24 For instance, in cultured dorsal root ganglion cells that express GluR5 subunits, activation of GluR5-containing kainate receptors induces a metabotropic action with release of Ca 2ϩ from intracellular stores through activation of G proteins and phospholipase C. 24 We loaded spinal axons with PTX (see Materials and Methods) designed to inhibit G-protein signaling. Under these conditions, the axonal Ca 2ϩ increase in response to ATPA application was greatly reduced (F Ca.ax increase: 17 Ϯ 28%, n ϭ 38, p ϭ 10 Ϫ5 vs no PTX). Moreover, either inhibition , coupled with the significant inhibitory effects of ryanodine, indicates that although AMPA receptors do permeate Ca 2ϩ directly, the majority of the resulting axonal Ca 2ϩ signal is due to CICR from ryanodine-dependent intracellular stores, similar to CICR classically described in cardiac muscle cells. 25 However, unlike cardiac myocytes, the initial Ca "trigger" appears to be delivered by Ca 2ϩ -permeable AMPA receptors; this is consistent with the strong inhibitory effect of 1-naphthyl acetyl spermine, a selective inhibitor of GluR2-lacking, Ca 2ϩ -permeable AMPA receptors, on the AMPA-induced Ca 2ϩ increase (see Fig 1) . Together with our previous data from spinal axons showing that depolarization promotes Ca 2ϩ release from ryanodine-sensitive Ca 2ϩ stores, 22 these results indicate that axons exhibit both a depolarization-induced (skeletal muscle type, dependent on ryanodine receptor 1 [RyR1]) and a Ca 2ϩ -induced (cardiac muscle type, RyR2) Ca 2ϩ release. Indeed, both RyR1 and RyR2 are expressed in these axons 22 ; whether AMPA receptor-mediated Ca 2ϩ influx indicated by this study acts selectively on axonal RyR2 is currently unknown, however. Ca 2ϩ release via IP3 receptors is also known to be potentiated by increased cytosolic-Ca 2ϩ in a biphasic manner. 26 The significant, though incomplete, reduction of Ca 2ϩ increase by zero-Ca 2ϩ perfusion in response to ATPA is consistent with a dual action of GluR5s', reflecting a small component of Ca 2ϩ entry (see the next section) coupled with a strong metabotropic action dependent on G proteins and IP3 synthesis.
The protective effect of AMPA/kainate receptor antagonists in different white matter injury paradigms was suggested to be secondary to sparing of glial elements, possibly leading to a reduction of diffusible messengers (eg, nitric oxide [NO] and free radicals) that may potentially damage axons (for review, see Matute and colleagues 9 ). To investigate a potential role of NO in the AMPA-or ATPA-induced Ca 2ϩ responses, we used the NO scavenger myoglobin. 27 Selective intracellular loading of axons with myoglobin, which will scavenge NO originating both from within and from outside the axon, significantly reduced axoplasmic Ca 2ϩ increase induced by ATPA (61 Ϯ 34%; n ϭ 45; p ϭ 10 Ϫ8 vs no myoglobin) but did not reduce the AMPA response (92 Ϯ 36%; n ϭ 29; p ϭ 0.95 vs no myoglobin), suggesting that only the GluR5-mediated ATPA response depended (at least partially) on NO production (Fig 3) . To demonstrate an intraaxonal action of NO in response to GluR5 activation, we repeated the ATPA experiment with bathapplied myoglobin, which failed to blunt the axonal Ca 2ϩ response (F Ca.ax increase: 144 Ϯ 39%; n ϭ 24; p ϭ 0.99 vs no bath-applied myoglobin). Together, the earlier results suggest a close functional relation between GluR5 kainate receptors and NO production in myelinated axons, likely synthesized by nNOS. Indeed, the partial reduction of the GluR5-mediated Ca 2ϩ re- sponse by removal of bath Ca 2ϩ is remarkably similar to that seen with intraaxonal myoglobin (see Fig 3) ( p ϭ 0.93). Moreover, combined removal of bath Ca 2ϩ and intraaxonal myoglobin is not additive (F Ca.ax increase: 38 Ϯ 36%, n ϭ 33, p Ϸ 1 vs ATPAϩ zeroCa 2ϩ /EGTA; p ϭ 0.66 vs ATPAϩ intraaxonal myoglobin). nNOS is a Ca 2ϩ -activated enzyme 28 ; therefore, it is quite plausible that the small quantity of Ca 2ϩ admitted across the axolemma by GluR5 serves to promote NO synthesis, which, in turn, may amplify the "metabotropic" arm of the GluR5-dependent pathway, ultimately leading to Ca 2ϩ release from IP3-dependent stores. This Ca 2ϩ release can further enhance nNOS function (eg, Xu and colleagues 29 ), thus providing Ca 2ϩ -dependent positive feedback in an environment (ie, the periaxonal space) where sources of Ca 2ϩ are limited. Further evidence linking GluR5 with NO synthesis by nNOS is provided by immunochemical methods.
Fig 3. Glutamate receptor 5 (GluR5), but not ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA; grey bars), receptor-induced axonal Ca 2ϩ responses partially depended on intraaxonal nitric oxide (NO). Intraaxonal loading of the NO scavenger myoglobin significantly reduced the Ca 2ϩ response induced by (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-
Immunohistochemical characterization of GluR5 and nNOS in dorsal columns showed frequent punctate staining at the surfaces of neurofilament-positive axon cylinders (Fig 4) . Approximately 39% of GluR5 clusters present at the axon surface were colocalized with nNOS (see Fig 4F) ; conversely, 58% of nNOS clusters were colocalized with punctate GluR5 staining. This indicates that these signaling molecules may be distributed for other roles, such as nNOS association with the axonal GluR6 kainate receptor subtype. 1 Moreover, immunoelectron microscopy confirmed that many GluR5-positive clusters were localized to the axolemma, rather than overlying myelin (see Fig 4G) . In addition, immunoprecipitation of dorsal column lysate with a GluR5 antibody resulted in a strong band immunoreactive for nNOS (see Fig 4H) , indicating that these proteins are physically associated in this tissue. Taken together, these data are consistent with expression of GluR5 kainate receptors on the internodal axolemma and suggest that these receptors activate nNOS to generate intraaxonal NO. A similar punctate staining pattern was observed for GluR4 (see Fig 4A) , indicating that AMPA receptors are also expressed on the axolemma under the internodal myelin sheath, further supported by the immunogold staining in Figure 4C .
Discussion
Glutamate-mediated toxicity of white matter has been described in several studies, many of which have implicated glutamate receptors 2,4,14 -16,18 ; glutathione depletion by glutamate-cystine exchange in oligodendrocytes, also plays a role in glutamate-dependent damage in cultured oligodendrocytes. 30 These glia, which have been shown in vivo and in vitro to be particularly sensitive to excitotoxic insults, were considered the main cellular target of glutamate action, 9 whereas astrocytes appear far more resistant to this neurotransmitter. 30 Here, we show that, in addition to a glial effect of glutamate, GluR5-containing kainate receptors and GluR4-containing AMPA receptors are expressed on the internodal axolemma in central myelinated fibers and directly participate in mediating axonal Ca 2ϩ increases in responses to agonist. These receptors are well poised to mediate deleterious Ca 2ϩ deregulation in axons; indeed, white matter vulnerability to ischemia increases with age, 31 and it is quite conceivable that these axonal receptors are directly responsible for promoting axonal degeneration in a variety of disease states.
The numerous colocalized and physically associated GluR5 receptors and nNOS clusters distributed along axon cylinders are similar to previously reported Ca 2ϩ channel/ryanodine receptor clusters 22 and GluR6/ nNOS "nanocomplexes."
1 It appears, therefore, that the internodal axolemma exhibits an even richer collection of signaling molecules than was previously thought, now including GluR4, GluR5, and GluR6, the latter two physically and functionally associated with nNOS. The focal clustering of the above receptors and downstream effector molecules is curious, and suggests that the internodal axolemma is an inhomogeneous structure exhibiting highly specialized and spatially restricted functions. Indeed, in this study, GluR4 AMPA receptors appear to admit small amounts of extracellular Ca 2ϩ , which is then amplified by CICR, dependent on ryanodine receptors. Unlike depolarizationinduced Ca 2ϩ release, 22 or GluR6-mediated Ca 2ϩ increase, 1 the AMPA receptor-dependent responses are independent of L-type Ca 2ϩ channels, but instead appear dependent on Ca 2ϩ ions admitted through the Ca 2ϩ -permeable receptor itself. CICR can be triggered by Ca 2ϩ -permeable channels other than voltage-gated channels; in dendritic spines, for instance, N-methyl-D-aspartate receptor-mediated Ca 2ϩ influx triggers Ca 2ϩ release from ryanodine-sensitive stores. 32 The purpose of CICR in axons is unknown but may parallel other cells where internal Ca 2ϩ provides the majority of a biochemical signal. In cardiac myocytes, for instance, 80% of the Ca 2ϩ responsible for contraction originates from the sarcoplasmic reticulum, mobilized via CICR. 33 It is likely that myelination heavily restricts the availability of extracellular Ca 2ϩ for signaling in the internodal periaxonal space; therefore, axons may have adopted a strategy for amplifying these Ca 2ϩ signals by instead relying on internal sources, with a small influx of this ion across the axolemma being a sufficient trigger. In contrast with the AMPA-mediated responses, the GluR5-mediated Ca 2ϩ increase occurs by both canonical (ie, ionotropic) and noncanonical (metabotropic) signaling, whereby a small inflow of Ca 2ϩ is amplified through a G-protein, phospholipase C-dependent cascade, ultimately leading to Ca 2ϩ release from IP3-dependent Ca 2ϩ stores. In contrast with the AMPA-dependent effect, this GluR5-mediated mechanism is upregulated by NO, likely synthesized by nNOS within the axon; the mechanism by which NO stimulates IP3-dependent Ca 2ϩ release is unknown but may involve direct or indirect (via activation of soluble guanylate cyclase) activation of IP3 receptor activity 34 (see Fig 6 in the accompanying article  1 ). Axonal pathology from many different insults such as ischemia, trauma, and immune attack shares remarkable similarities, with focal swelling and often irreversible transection of the fiber. 35 Although the pathophysiological mechanisms of axonal swelling and transection are unknown, it is interesting to speculate that the highly localized clusters of signaling molecules on the internodal axolemma, each leading to localized Ca 2ϩ release, may induce focal destruction of axonal cytoarchitecture, in turn possibly leading to the localized axonal pathology observed in many disorders. If so, this raises interesting therapeutic possibilities to re- duce axonal damage in many disorders such neurotrauma, multiple sclerosis, and stroke. Our observations further underscore the parallels between neurons and myelinated axons with respect to the "source specificity" of Ca 2ϩ loading, whereby the locus of Ca 2ϩ entry (via channels)/release (from intracellular Ca 2ϩ stores) may be more important than the total cellular Ca 2ϩ load. 36, 37 
